Disabled homolog 2 controls macrophage phenotypic polarization and adipose tissue inflammation

Journal of Clinical Investigation

Volumn 126, Issue 4, 2016, Pages 1311-1322

  Adamson, Samantha E ^a,b   Griffiths, Rachael ^a,b   Moravec, Radim ^a   Senthivinayagam, Subramanian ^a   Montgomery, Garren ^a   Chen, Wenshu ^a   Han, Jenny ^a   Sharma, Poonam R ^a   Mullins, Garrett R ^a   Gorski, Stacey A ^a   Cooper, Jonathan A ^c   Kadl, Alexandra ^a   Enfield, Kyle ^a   Braciale, Thomas J ^a   Harris, Thurl E ^a   Leitinger, Norbert ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; ADAPTOR PROTEIN DISABLED HOMOLOG 2; I KAPPA B KINASE BETA; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG; DAB2 PROTEIN, HUMAN; DAB2 PROTEIN, MOUSE; I KAPPA B KINASE; RELA PROTEIN, HUMAN; RELA PROTEIN, MOUSE; SIGNAL PEPTIDE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TAX1BP1 PROTEIN, HUMAN; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ADIPOSE TISSUE; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MACROPHAGE; MACROPHAGE ACTIVATION; MUTATIONAL ANALYSIS; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION; UPREGULATION; ANIMAL; BIOSYNTHESIS; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; KNOCKOUT MOUSE; METABOLISM; MOUSE; PANNICULITIS; PATHOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADAPTOR PROTEINS, VESICULAR TRANSPORT; ADIPOSE TISSUE; ANIMALS; CELL LINE; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; I-KAPPA B KINASE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGES; MICE; MICE, KNOCKOUT; NEOPLASM PROTEINS; PANNICULITIS; TRANSCRIPTION FACTOR RELA; TUMOR SUPPRESSOR PROTEINS;

EID: 84964576078     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI79590     Document Type: Article

References (49)

1. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol. 2005;5(12):953-964.
2. Lawrence T, Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol. 2011;11(11):750-761.
3. Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol. 2012;229(2):176-185.
4. Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol. 2011;11(11):723-737.
5. Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol. 2010;11(10):889-896.
6. Fairweather D, Cihakova D. Alternatively activated macrophages in infection and autoimmunity. J Autoimmun. 2009;33(3-4):222-230.
7. Mantovani A, Garlanda C, Locati M. Macrophage diversity and polarization in atherosclerosis: A question of balance. Arterioscler Thromb Vasc Biol. 2009;29(10):1419-1423.
8. Adamson S, Leitinger N. Phenotypic modulation of macrophages in response to plaque lipids. Curr Opin Lipidol. 2011;22(5):335-342.
9. Kadl A, et al. Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2. Circ Res. 2010;107(6):737-746.
10. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest. 2007;117(1):175-184.
11. Chawla A, Nguyen KD, Goh YPS. Macrophagemediated inflammation in metabolic disease. Nat Rev Immunol. 2011;11(11):738-749.
12. Hagemann T, et al. "Re-educating" tumor-associated macrophages by targeting NF-κB. J Exp Med. 2008;205(6):1261-1268.
13. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25(12):677-686.
14. Martinez FO. Macrophage activation and polarization. Front Biosci. 2008;13(13):453.
15. Lawrence T, Bebien M, Liu GY, Nizet V, Karin M. IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation. Nature. 2005;434(7037):1138-1143.
16. Fong CH, et al. An antiinflammatory role for IKKβ through the inhibition of "classical" macrophage activation. J Exp Med. 2008;205(6):1269-1276.
17. Adhikari A, Xu M, Chen ZJ. Ubiquitin-mediated activation of TAK1 and IKK. Oncogene. 2007;26(22):3214-3226.
18. Lee J, Mira-Arbibe L, Ulevitch RJ. TAK1 regulates multiple protein kinase cascades activated by bacterial lipopolysaccharide. J Leukoc Biol. 2000;68(6):909-915.
19. Jeong SJ, Pise-Masison CA, Radonovich MF, Park HU, Brady JN. A novel NF-κB pathway involving IKKβ and p65/RelA Ser-536 phosphorylation results in p53 Inhibition in the absence of NF-κB transcriptional activity. J Biol Chem. 2005;280(11):10326-10332.
20. Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W. IκB kinases phosphorylate NF-κB p65 subunit on serine 536 in the transactivation domain. J Biol Chem. 1999;274(43):30353-30356.
21. Finkielstein CV, Capelluto DGS. Disabled-2: A modular scaffold protein with multifaceted functions in signaling. Inside the Cell. 2016;1(1):48-58.
22. Xu XX, Yang W, Jackowski S, Rock CO. Cloning of a novel phosphoprotein regulated by colonystimulating factor 1 shares a domain with the Drosophila disabled gene product. J Biol Chem. 1995;270(23):14184-14191.
23. Yun M, et al. Crystal structures of the Dab homology domains of mouse disabled 1 and 2. J Biol Chem. 2003;278(38):36572-36581.
24. Albertsen HM, et al. Sequence, genomic structure, and chromosomal assignment of human DOC-2. Genomics. 1996;33(2):207-213.
25. Morris SM. Dual roles for the Dab2 adaptor protein in embryonic development and kidney transport. EMBO J. 2002;21(7):1555-1564.
26. Maurer ME, Cooper JA. The adaptor protein Dab2 sorts LDL receptors into coated pits independently of AP-2 and ARH. J Cell Sci. 2006;119(20):4235-4246.
27. Oleinikov AV, Zhao J, Makker SP. Cytosolic adaptor protein Dab2 is an intracellular ligand of endocytic receptor gp600/megalin. Biochem J. 2000;347(3):613.
28. Penheiter SG, et al. Type II transforming growth factor-beta receptor recycling is dependent upon the clathrin adaptor protein Dab2. Mol Biol Cell. 2010;21(22):4009-4019.
29. Nakayama M, et al. Spatial regulation of VEGF receptor endocytosis in angiogenesis. Nat Cell Biol. 2013;15(3):249-260.
30. Madden DR, Swiatecka-Urban A. Tissue-specific control of CFTR endocytosis by Dab2. Commun Integr Biol. 2012;5(5):473-476.
31. Fu L, Rab A, Tang L, Rowe S, Bebok Z, Collawn J. Dab2 is a key regulator of endocytosis and post-endocytic trafficking of the cystic fibrosis transmembrane conductance regulator. Biochem J. 2011;441(2):633-643.
32. Morris SM, Cooper JA. Disabled-2 colocalizes with the LDLR in clathrin-coated pits and interacts with AP-2. Traffic. 2001;2(2):111-123.
33. Hocevar BA. Regulation of the Wnt signaling pathway by disabled-2 (Dab2). EMBO J. 2003;22(12):3084-3094.
34. Jain N, et al. Cutting edge: Dab2 is a FOXP3 target gene required for regulatory T cell function. J Immunol. 2009;183(7):4192-4196.
35. Karam JA, et al. Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder. Clin Cancer Res. 2007;13(15):4400-4406.
36. Bagadi SAR, Prasad CP, Srivastava A, Prashad R, Gupta SD, Ralhan R. Frequent loss of Dab2 protein and infrequent promoter hypermethylation in breast cancer. Breast Cancer Res Treat. 2006;104(3):277-286.
37. Sheng Z, et al. Structure, sequence, and promoter analysis of human disabled-2 gene (DAB2). Genomics. 2000;70(3):381-386.
38. Hannigan A, et al. Epigenetic downregulation of human disabled homolog 2 switches TGF-β from a tumor suppressor to a tumor promoter. J Clin Invest. 2010;120(8):2842-2857.
39. Tong JH, et al. Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma. BMC Cancer. 2010;10(1):253.
40. Rosenbauer F, et al. Disabled-2 is transcriptionally regulated by ICSBP and augments macrophage spreading and adhesion. EMBO J. 2002;21(3):211-220.
41. Jokubaitis VG, et al. Endogenously regulated Dab2 worsens inflammatory injury in experimental autoimmune encephalomyelitis. Acta Neuropathol Commun. 2013;1(1):32.
42. Prunier C, Howe PH. Disabled-2 (Dab2) is required for transforming growth factor β-induced epithelial to mesenchymal transition (EMT). J Biol Chem. 2005;280(17):17540-17548.
43. Kadl A, Pontiller J, Exner M, Leitinger N. Single bolus injection of bilirubin improves the clinical outcome in a mouse model of endotoxemia. Shock. 2007;28(5):582-588.
44. Talukdar S, et al. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat Med. 2012;18(9):1407-1412.
45. Weisberg SP, et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest. 2006;116(1):115-124.
46. Ma Q, Zhou L, Shi H, Huo K. NUMBL interacts with TAB2 and inhibits TNFα and IL-1β-induced NF-κB activation. Cell Signal. 2008;20(6):1044-1051.
47. Zhou L, Ma Q, Shi H, Huo K. NUMBL interacts with TRAF6 and promotes the degradation of TRAF6. Biochem Biophys Res Commun. 2010;392(3):409-414.
48. Cho SY, Jeon JW, Lee SH, Park SS. p67 isoform of mouse disabled 2 protein acts as a transcriptional activator during the differentiation of F9 cells. Biochem J. 2000;352(3):645.
49. Landström M. The TAK1-TRAF6 signalling pathway. Int J Biochem Cell Biol. 2010;42(5):585-589.